chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills
Clinical narrative: Feels likes a burning sensation to the spine/It feel like burning is on the skin and there is nothing there; chills; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Feels likes a burning sensation to the spine/It feel like burning is on the skin and there is nothing there) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Feels likes a burning sensation to the spine/It feel like burning is on the skin and there is nothing there) and CHILLS (chills). At the time of the report, BURNING SENSATION (Feels likes a burning sensation to the spine/It feel like burning is on the skin and there is nothing there) and CHILLS (chills) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia
Clinical narrative: (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced DYSPHAGIA (difficulty in swallowing). At the time of the report, DYSPHAGIA (difficulty in swallowing) had not resolved. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient take medicine for allergies as a Concomitant drug  No treatment medication was provided b reporter
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Pyrexia, Vaccination site rash
Clinical narrative: Sore arm; Itching; Rash at the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PRURITUS (Itching), VACCINATION SITE RASH (Rash at the injection site) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PRURITUS (Itching), VACCINATION SITE RASH (Rash at the injection site) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), PRURITUS (Itching), VACCINATION SITE RASH (Rash at the injection site) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included, Steroids. List of concomitant medication were not given.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: TCR: nonsafety info
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: nausea; severe pain in legs and back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in legs and back) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (severe pain in legs and back). On an unknown date, the patient experienced NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (severe pain in legs and back) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Non-Significant FU- Declined consent for further FU
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersensitivity, Vaccination site mass, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Covid arm; arm of injection itchy; Arm of injection with a lamp; Arm of injection swollen; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Arm of injection with a lamp), HYPERSENSITIVITY (Covid arm), VACCINATION SITE SWELLING (Arm of injection swollen), HEADACHE (Headache) and VACCINATION SITE PRURITUS (arm of injection itchy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Diabetes.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE MASS (Arm of injection with a lamp), VACCINATION SITE SWELLING (Arm of injection swollen) and HEADACHE (Headache). On 07-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (arm of injection itchy). On an unknown date, the patient experienced HYPERSENSITIVITY (Covid arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (Arm of injection with a lamp), VACCINATION SITE SWELLING (Arm of injection swollen), HEADACHE (Headache) and VACCINATION SITE PRURITUS (arm of injection itchy) had not resolved and HYPERSENSITIVITY (Covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient take medicine for blood pressure and medicine for diabetes in concomitant medication.  Patient take Tylenol and ice as a Treatment medication
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Soreness at the injection; Muscle pain/achiness; Joint pain; Headache; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection), MYALGIA (Muscle pain/achiness), ARTHRALGIA (Joint pain), HEADACHE (Headache) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection), MYALGIA (Muscle pain/achiness), ARTHRALGIA (Joint pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection), MYALGIA (Muscle pain/achiness), ARTHRALGIA (Joint pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included paracetamol.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow-up received on 22-Apr-2021 contains no new information as email for the reporter was added
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at the injection; Muscle pain/achiness; Joint pain; Headache; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection), MYALGIA (Muscle pain/achiness), ARTHRALGIA (Joint pain), HEADACHE (Headache) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection), MYALGIA (Muscle pain/achiness), ARTHRALGIA (Joint pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection), MYALGIA (Muscle pain/achiness), ARTHRALGIA (Joint pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included paracetamol.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow-up received on 22-Apr-2021 contains no new information as email for the reporter was added
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Tenderness, Tremor
Clinical narrative: Tenderness in arm; Hands shook; Fever of 104; Teeth chattered; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness in arm), TREMOR (Hands shook), PYREXIA (Fever of 104) and CHILLS (Teeth chattered) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included APIXABAN (ELIQUIS) and METOPROLOL for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (Tenderness in arm), TREMOR (Hands shook), PYREXIA (Fever of 104) and CHILLS (Teeth chattered). At the time of the report, TENDERNESS (Tenderness in arm), TREMOR (Hands shook), PYREXIA (Fever of 104) and CHILLS (Teeth chattered) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (Inconclusive) 104 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications provided by the reporter.    This case was linked to MOD21-026293 (E2B Linked Report).; Sender's Comments:  MOD21-026293:Patient husband case
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site movement impairment
Clinical narrative: Unable to lift injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to lift injection arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to lift injection arm). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to lift injection arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow up received contains Event outcome was updated to resolved.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Feeling abnormal, Headache, Nausea
Clinical narrative: She went to work for 2hrs and had to come home.; Threw up; She felt nauseous; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She went to work for 2hrs and had to come home.), DISCOMFORT (Threw up), NAUSEA (She felt nauseous), CHILLS (Chills) and HEADACHE (Headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Bladder disorder (She has a bladder disorder and takes meds for that.). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL (TYLENOL PM) for an unknown indication.    On 09-Feb-2021 at 1:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced FEELING ABNORMAL (She went to work for 2hrs and had to come home.), DISCOMFORT (Threw up), NAUSEA (She felt nauseous), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, FEELING ABNORMAL (She went to work for 2hrs and had to come home.), DISCOMFORT (Threw up), NAUSEA (She felt nauseous), CHILLS (Chills) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient take took 2 Tylenol PM and a migraine pill and Anti nauseous pill.  Patient take Medication for bladder disorder
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and MYALGIA (body aches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (headache) and MYALGIA (body aches). At the time of the report, HEADACHE (headache) and MYALGIA (body aches) had not resolved. Not Provided          No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-1 test, Type IV hypersensitivity reaction
Clinical narrative: delayed reaction; This spontaneous case was reported by a nurse and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (delayed reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (delayed reaction). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (delayed reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-1 test: positive (Positive) tested positive on 23-24 JAN2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD21-16356, MOD21-16452, MOD21-16453, MOD21-16454, MOD21-16456, MOD21-16457 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow up received on 18-Jun-2021, no new information was recorded
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HERPES ZOSTER (Mild Shingles around eyes). At the time of the report, HERPES ZOSTER (Mild Shingles around eyes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     Concomitant products included blood pressure medicine, APIXABAN (ELIQUIS) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details included went doctor last week and gave her to take Montelukast scd 10mg 1 day and hydroxyzine hcl, 25mg, and cream ointment. She takes 2 Benadryl before going to bed and cortisone at night.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Malaise, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID19; shortness of breath; headache; loss of 20 pounds; really high fever; Felt very sick; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), PYREXIA (really high fever) and MALAISE (Felt very sick) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), PYREXIA (really high fever) and MALAISE (Felt very sick). On 21-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19). On 28-Jan-2021, PYREXIA (really high fever) had resolved. At the time of the report, DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), MALAISE (Felt very sick) and SARS-COV-2 TEST POSITIVE (Tested positive for COVID19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included Steroids, acetaminophen, Inhaler and other OTC medicines
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Tested positive for COVID19; shortness of breath; headache; loss of 20 pounds; really high fever; Felt very sick; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), PYREXIA (really high fever) and MALAISE (Felt very sick) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), PYREXIA (really high fever) and MALAISE (Felt very sick). On 21-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19). On 28-Jan-2021, PYREXIA (really high fever) had resolved. At the time of the report, DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), MALAISE (Felt very sick) and SARS-COV-2 TEST POSITIVE (Tested positive for COVID19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included Steroids, acetaminophen, Inhaler and other OTC medicines
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait inability, Migraine, Myalgia, Nausea
Clinical narrative: migraine; unable to walk; nausea/vomiting; nausea/vomiting; Muscle pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), GAIT INABILITY (unable to walk), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and MYALGIA (Muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (migraine), GAIT INABILITY (unable to walk), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting), MYALGIA (Muscle pain) and FATIGUE (fatigue). At the time of the report, MIGRAINE (migraine), GAIT INABILITY (unable to walk), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting), MYALGIA (Muscle pain) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: migraine; unable to walk; nausea/vomiting; nausea/vomiting; Muscle pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), GAIT INABILITY (unable to walk), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and MYALGIA (Muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (migraine), GAIT INABILITY (unable to walk), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting), MYALGIA (Muscle pain) and FATIGUE (fatigue). At the time of the report, MIGRAINE (migraine), GAIT INABILITY (unable to walk), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting), MYALGIA (Muscle pain) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Nasopharyngitis
Clinical narrative: very cold; flu like symptoms; Patient is experiencing chills/cannot get warm; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (very cold), INFLUENZA LIKE ILLNESS (flu like symptoms) and CHILLS (Patient is experiencing chills/cannot get warm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced NASOPHARYNGITIS (very cold), INFLUENZA LIKE ILLNESS (flu like symptoms) and CHILLS (Patient is experiencing chills/cannot get warm). At the time of the report, NASOPHARYNGITIS (very cold), INFLUENZA LIKE ILLNESS (flu like symptoms) and CHILLS (Patient is experiencing chills/cannot get warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Erythema, Lymph node pain, Lymphadenopathy, Malaise
Clinical narrative: lymph nodes swollen; Both armpit's lymph nodes red; Both armpit's lymph nodes painful; Both armpit's were painful; Felt extremely sick; Pain/Body aches; Injection site pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt extremely sick), PAIN (Pain/Body aches), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever) and AXILLARY PAIN (Both armpit's were painful) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced MALAISE (Felt extremely sick), PAIN (Pain/Body aches), VACCINATION SITE PAIN (Injection site pain) and PYREXIA (Fever). On 10-Feb-2021, the patient experienced AXILLARY PAIN (Both armpit's were painful). On 11-Feb-2021, the patient experienced LYMPHADENOPATHY (lymph nodes swollen), ERYTHEMA (Both armpit's lymph nodes red) and LYMPH NODE PAIN (Both armpit's lymph nodes painful). At the time of the report, MALAISE (Felt extremely sick), PAIN (Pain/Body aches), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever), AXILLARY PAIN (Both armpit's were painful), LYMPHADENOPATHY (lymph nodes swollen), ERYTHEMA (Both armpit's lymph nodes red) and LYMPH NODE PAIN (Both armpit's lymph nodes painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter. Treatment details included Tylenol   Reporter did not allow further contact
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain
Clinical narrative: lymph nodes swollen; Both armpit's lymph nodes red; Both armpit's lymph nodes painful; Both armpit's were painful; Felt extremely sick; Pain/Body aches; Injection site pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt extremely sick), PAIN (Pain/Body aches), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever) and AXILLARY PAIN (Both armpit's were painful) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced MALAISE (Felt extremely sick), PAIN (Pain/Body aches), VACCINATION SITE PAIN (Injection site pain) and PYREXIA (Fever). On 10-Feb-2021, the patient experienced AXILLARY PAIN (Both armpit's were painful). On 11-Feb-2021, the patient experienced LYMPHADENOPATHY (lymph nodes swollen), ERYTHEMA (Both armpit's lymph nodes red) and LYMPH NODE PAIN (Both armpit's lymph nodes painful). At the time of the report, MALAISE (Felt extremely sick), PAIN (Pain/Body aches), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever), AXILLARY PAIN (Both armpit's were painful), LYMPHADENOPATHY (lymph nodes swollen), ERYTHEMA (Both armpit's lymph nodes red) and LYMPH NODE PAIN (Both armpit's lymph nodes painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter. Treatment details included Tylenol   Reporter did not allow further contact
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Influenza like illness, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Started feeling weird), INFLUENZA LIKE ILLNESS (Slight flu-like symptoms) and SARS-COV-2 TEST POSITIVE (Tested positive for Covid) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced FEELING ABNORMAL (Started feeling weird). On 02-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Slight flu-like symptoms). On 03-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for Covid). At the time of the report, FEELING ABNORMAL (Started feeling weird), INFLUENZA LIKE ILLNESS (Slight flu-like symptoms) and SARS-COV-2 TEST POSITIVE (Tested positive for Covid) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, SARS-CoV-2 test: positive (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Limb discomfort
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep for three days), LIMB DISCOMFORT (light discomfort in the arm) and INSOMNIA (could not sleep in the whole night) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 012M20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2021, the patient experienced INSOMNIA (could not sleep for three days). On 10-Feb-2021, the patient experienced LIMB DISCOMFORT (light discomfort in the arm) and INSOMNIA (could not sleep in the whole night). On 14-Jan-2021, INSOMNIA (could not sleep for three days) outcome was unknown. At the time of the report, LIMB DISCOMFORT (light discomfort in the arm) and INSOMNIA (could not sleep in the whole night) outcome was unknown. Not Provided. Concomitant medications reported were blood thinners, medication for hernia cancer. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: rash on my neck and around my eyes; warm around injection site; itchy around injection site; Red blotch on upper arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red blotch on upper arm), RASH (rash on my neck and around my eyes), VACCINATION SITE WARMTH (warm around injection site) and VACCINATION SITE PRURITUS (itchy around injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (sulfur allergy).    On 29-Jan-2021 at 4:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced ERYTHEMA (Red blotch on upper arm), VACCINATION SITE WARMTH (warm around injection site) and VACCINATION SITE PRURITUS (itchy around injection site). On an unknown date, the patient experienced RASH (rash on my neck and around my eyes). At the time of the report, ERYTHEMA (Red blotch on upper arm) had not resolved, RASH (rash on my neck and around my eyes) outcome was unknown and VACCINATION SITE WARMTH (warm around injection site) and VACCINATION SITE PRURITUS (itchy around injection site) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: VAERS Form received on 10-MAY-2021
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Heart rate increased, Hypoaesthesia, Myalgia
Clinical narrative: Numbness and tingling throughout the body; Had an uneasy night and fidgeting too much; Nausea on and off; Fever; Joint and muscle pain; Joint and muscle pain; Fatigue; Experiencing parasthesias; Vertigo; Elevated heart rate; Numbness and tingling throughout the body; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), HEART RATE INCREASED (Elevated heart rate), HYPOAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Numbness and tingling throughout the body) and PARAESTHESIA (Experiencing parasthesias) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included NAPROXEN for an unknown indication.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VERTIGO (Vertigo), HEART RATE INCREASED (Elevated heart rate), HYPOAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Experiencing parasthesias), NAUSEA (Nausea on and off), PYREXIA (Fever), ARTHRALGIA (Joint and muscle pain), MYALGIA (Joint and muscle pain) and FATIGUE (Fatigue). On an unknown date, the patient experienced PARAESTHESIA (Numbness and tingling throughout the body) and RESTLESSNESS (Had an uneasy night and fidgeting too much). At the time of the report, VERTIGO (Vertigo), HEART RATE INCREASED (Elevated heart rate), HYPOAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Experiencing parasthesias), RESTLESSNESS (Had an uneasy night and fidgeting too much), NAUSEA (Nausea on and off), PYREXIA (Fever), ARTHRALGIA (Joint and muscle pain), MYALGIA (Joint and muscle pain) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medication Naproxen (as needed), Hormones. Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Paraesthesia, Pyrexia, Restlessness, Vertigo
Clinical narrative: Numbness and tingling throughout the body; Had an uneasy night and fidgeting too much; Nausea on and off; Fever; Joint and muscle pain; Joint and muscle pain; Fatigue; Experiencing parasthesias; Vertigo; Elevated heart rate; Numbness and tingling throughout the body; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), HEART RATE INCREASED (Elevated heart rate), HYPOAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Numbness and tingling throughout the body) and PARAESTHESIA (Experiencing parasthesias) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included NAPROXEN for an unknown indication.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VERTIGO (Vertigo), HEART RATE INCREASED (Elevated heart rate), HYPOAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Experiencing parasthesias), NAUSEA (Nausea on and off), PYREXIA (Fever), ARTHRALGIA (Joint and muscle pain), MYALGIA (Joint and muscle pain) and FATIGUE (Fatigue). On an unknown date, the patient experienced PARAESTHESIA (Numbness and tingling throughout the body) and RESTLESSNESS (Had an uneasy night and fidgeting too much). At the time of the report, VERTIGO (Vertigo), HEART RATE INCREASED (Elevated heart rate), HYPOAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Numbness and tingling throughout the body), PARAESTHESIA (Experiencing parasthesias), RESTLESSNESS (Had an uneasy night and fidgeting too much), NAUSEA (Nausea on and off), PYREXIA (Fever), ARTHRALGIA (Joint and muscle pain), MYALGIA (Joint and muscle pain) and FATIGUE (Fatigue) outcome was unknown.            Concomitant medication Naproxen (as needed), Hormones. Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Feeling abnormal, Headache, Pyrexia
Clinical narrative: stomach ache; fever; fatigue; headache; running nose; Not feeling good; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever), FATIGUE (fatigue), HEADACHE (headache) and RHINORRHOEA (running nose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE, METOPROLOL, VITAMIN D3, PROBIOTICS NOS, VITAMINS NOS, CALCIUM, ASCORBIC ACID (VITAMIN C ACID), ACETYLSALICYLIC ACID (ASPIRIN 81) and SIMVASTATIN for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever), FATIGUE (fatigue), HEADACHE (headache), RHINORRHOEA (running nose) and FEELING ABNORMAL (Not feeling good). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever), FATIGUE (fatigue), HEADACHE (headache), RHINORRHOEA (running nose) and FEELING ABNORMAL (Not feeling good) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Treatment details were not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: stomach ache; fever; fatigue; headache; running nose; Not feeling good; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever), FATIGUE (fatigue), HEADACHE (headache) and RHINORRHOEA (running nose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE, METOPROLOL, VITAMIN D3, PROBIOTICS NOS, VITAMINS NOS, CALCIUM, ASCORBIC ACID (VITAMIN C ACID), ACETYLSALICYLIC ACID (ASPIRIN 81) and SIMVASTATIN for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever), FATIGUE (fatigue), HEADACHE (headache), RHINORRHOEA (running nose) and FEELING ABNORMAL (Not feeling good). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), PYREXIA (fever), FATIGUE (fatigue), HEADACHE (headache), RHINORRHOEA (running nose) and FEELING ABNORMAL (Not feeling good) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Paraesthesia
Clinical narrative: skipped his second vaccine; tingling sensation on his dorsal feet bilaterial/his hands had some tingling along within his face; This spontaneous case was reported by an other health care professional and describes the occurrence of PARAESTHESIA (tingling sensation on his dorsal feet bilaterial/his hands had some tingling along within his face) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (skipped his second vaccine) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced PARAESTHESIA (tingling sensation on his dorsal feet bilaterial/his hands had some tingling along within his face). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (skipped his second vaccine). At the time of the report, PARAESTHESIA (tingling sensation on his dorsal feet bilaterial/his hands had some tingling along within his face) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (skipped his second vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: COVID-19 positive; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) and SARS-COV-2 TEST POSITIVE (COVID-19 positive) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced RHINORRHOEA (Runny nose). On 11-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 positive). At the time of the report, RHINORRHOEA (Runny nose) and SARS-COV-2 TEST POSITIVE (COVID-19 positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported Treatment details included Infusion.   This case was linked to MOD21-027991 (E2B Linked Report).; Sender's Comments:  MOD21-027991:
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Fatigue, Nausea
Clinical narrative: got tested for COVID; shortness of breath; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), DYSPNOEA (shortness of breath), FATIGUE (fatigue) and COVID-19 (got tested for COVID) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concomitant products included Heart medicine, CHOLESTEROL and OTC vitamins for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced NAUSEA (nausea). On 01-Feb-2021, the patient experienced DYSPNOEA (shortness of breath) and FATIGUE (fatigue). On 02-Feb-2021, the patient experienced COVID-19 (got tested for COVID). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Jan-2021, NAUSEA (nausea) had resolved. At the time of the report, DYSPNOEA (shortness of breath), FATIGUE (fatigue) and COVID-19 (got tested for COVID) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Treatment details included Tylenol.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; A spontaneous report was received from a consumer concerning a 86 years old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events hives /urticaria.  The patient's medical history include heart problem, hypertension, allergy. Concomitant medications reported were HCTZ indicated for high blood pressure, Simvastatin indicated for heart disorder, amlodipine indicated for blood pressure, baby aspirin for drug used for unknown indication. chlorphenamine maleate indicated for allergies  On 14 Jan 2021, approximately 29 days prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: N A (Not on Card) intramuscularly in left arm for prophylaxis of COVID-19 infection. On 10 Feb 2021, approximately 2 days prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 013L20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 11 Feb 2021, the patient experienced the event(s) hives.  Treatment details included Ibuprofen.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  The outcome of event(s), hives was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood magnesium, Blood magnesium decreased, Pruritus
Clinical narrative: terrible itching; magnesium was low; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (terrible itching) and BLOOD MAGNESIUM DECREASED (magnesium was low) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (terrible itching) and BLOOD MAGNESIUM DECREASED (magnesium was low). At the time of the report, PRURITUS (terrible itching) and BLOOD MAGNESIUM DECREASED (magnesium was low) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Blood magnesium: Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were shot to stop itching. Treatment details included shot to stop the itching.